Growth pattern and body proportion in a female with short stature homeobox-containing gene overdosage and gonadal estrogen deficiency

Trutomu Ogata, Mikako Inokuchi, Masamichi Ogawa

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To report on growth pattern and body proportion in the combination of short stature homeobox-containing gene (SHOX) overdosage and gonadal estrogen deficiency. Design: Auxological studies in a 20-year-old Japanese female with 45,X[28]/46,X,psu idic(X)(q28)[72], gonadal estrogen deficiency, and SHOX duplication on the idic(X) chromosome, who received sex steroid replacement therapy from 16 years 8 months of age. Methods: Growth pattern and body proportion were assessed by the age-matched standards for Japanese females. Results: She continued to grow with a mean height velocity of 5.0 cm/year between 8 and 12 years of age and 4.4 cm/year between 12 and 16 years 8 months of age, and ceased to grow shortly after the replacement therapy. The standard deviation score (SDS) for height was -0.9, -1.4, +0.7 and +0.8 at 8, 12, 16 years 8 months and 20 years of age respectively. She showed a unique change in body proportion in her middle teens. At 8, 12, 16 years 8 months and 20 years of age, the SDS for sitting height (SH) was -0.8, -1.1, -0.9 and -0.6 respectively, the SDS for leg length (LL) was - 1.2, - 1.4, + 1.1 and + 1.4 respectively, and the SDS for SH/LL ratio was + 0.6, + 0.4, - 1.6 and - 1.7 respectively. Conclusions: The results provide further support for the notion that the combination of SHOX over-dosage and gonadal estrogen deficiency permits continued growth with a roughly constant height velocity throughout the pubertal period of normal children, and suggest that the height gain in that period is primarily ascribed to the LL increase, as expected from SHOX expression in the distal limb bone.

Original languageEnglish
Pages (from-to)249-254
Number of pages6
JournalEuropean Journal of Endocrinology
Volume147
Issue number2
Publication statusPublished - 2002 Aug

Fingerprint

Homeobox Genes
Estrogens
Leg
Growth
Gene Duplication
Gene Dosage
X Chromosome
Extremities
Steroids
Gene Expression
Bone and Bones
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Growth pattern and body proportion in a female with short stature homeobox-containing gene overdosage and gonadal estrogen deficiency. / Ogata, Trutomu; Inokuchi, Mikako; Ogawa, Masamichi.

In: European Journal of Endocrinology, Vol. 147, No. 2, 08.2002, p. 249-254.

Research output: Contribution to journalArticle

@article{41be82cfc7bb48d28f6dae03de167c55,
title = "Growth pattern and body proportion in a female with short stature homeobox-containing gene overdosage and gonadal estrogen deficiency",
abstract = "Objective: To report on growth pattern and body proportion in the combination of short stature homeobox-containing gene (SHOX) overdosage and gonadal estrogen deficiency. Design: Auxological studies in a 20-year-old Japanese female with 45,X[28]/46,X,psu idic(X)(q28)[72], gonadal estrogen deficiency, and SHOX duplication on the idic(X) chromosome, who received sex steroid replacement therapy from 16 years 8 months of age. Methods: Growth pattern and body proportion were assessed by the age-matched standards for Japanese females. Results: She continued to grow with a mean height velocity of 5.0 cm/year between 8 and 12 years of age and 4.4 cm/year between 12 and 16 years 8 months of age, and ceased to grow shortly after the replacement therapy. The standard deviation score (SDS) for height was -0.9, -1.4, +0.7 and +0.8 at 8, 12, 16 years 8 months and 20 years of age respectively. She showed a unique change in body proportion in her middle teens. At 8, 12, 16 years 8 months and 20 years of age, the SDS for sitting height (SH) was -0.8, -1.1, -0.9 and -0.6 respectively, the SDS for leg length (LL) was - 1.2, - 1.4, + 1.1 and + 1.4 respectively, and the SDS for SH/LL ratio was + 0.6, + 0.4, - 1.6 and - 1.7 respectively. Conclusions: The results provide further support for the notion that the combination of SHOX over-dosage and gonadal estrogen deficiency permits continued growth with a roughly constant height velocity throughout the pubertal period of normal children, and suggest that the height gain in that period is primarily ascribed to the LL increase, as expected from SHOX expression in the distal limb bone.",
author = "Trutomu Ogata and Mikako Inokuchi and Masamichi Ogawa",
year = "2002",
month = "8",
language = "English",
volume = "147",
pages = "249--254",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "2",

}

TY - JOUR

T1 - Growth pattern and body proportion in a female with short stature homeobox-containing gene overdosage and gonadal estrogen deficiency

AU - Ogata, Trutomu

AU - Inokuchi, Mikako

AU - Ogawa, Masamichi

PY - 2002/8

Y1 - 2002/8

N2 - Objective: To report on growth pattern and body proportion in the combination of short stature homeobox-containing gene (SHOX) overdosage and gonadal estrogen deficiency. Design: Auxological studies in a 20-year-old Japanese female with 45,X[28]/46,X,psu idic(X)(q28)[72], gonadal estrogen deficiency, and SHOX duplication on the idic(X) chromosome, who received sex steroid replacement therapy from 16 years 8 months of age. Methods: Growth pattern and body proportion were assessed by the age-matched standards for Japanese females. Results: She continued to grow with a mean height velocity of 5.0 cm/year between 8 and 12 years of age and 4.4 cm/year between 12 and 16 years 8 months of age, and ceased to grow shortly after the replacement therapy. The standard deviation score (SDS) for height was -0.9, -1.4, +0.7 and +0.8 at 8, 12, 16 years 8 months and 20 years of age respectively. She showed a unique change in body proportion in her middle teens. At 8, 12, 16 years 8 months and 20 years of age, the SDS for sitting height (SH) was -0.8, -1.1, -0.9 and -0.6 respectively, the SDS for leg length (LL) was - 1.2, - 1.4, + 1.1 and + 1.4 respectively, and the SDS for SH/LL ratio was + 0.6, + 0.4, - 1.6 and - 1.7 respectively. Conclusions: The results provide further support for the notion that the combination of SHOX over-dosage and gonadal estrogen deficiency permits continued growth with a roughly constant height velocity throughout the pubertal period of normal children, and suggest that the height gain in that period is primarily ascribed to the LL increase, as expected from SHOX expression in the distal limb bone.

AB - Objective: To report on growth pattern and body proportion in the combination of short stature homeobox-containing gene (SHOX) overdosage and gonadal estrogen deficiency. Design: Auxological studies in a 20-year-old Japanese female with 45,X[28]/46,X,psu idic(X)(q28)[72], gonadal estrogen deficiency, and SHOX duplication on the idic(X) chromosome, who received sex steroid replacement therapy from 16 years 8 months of age. Methods: Growth pattern and body proportion were assessed by the age-matched standards for Japanese females. Results: She continued to grow with a mean height velocity of 5.0 cm/year between 8 and 12 years of age and 4.4 cm/year between 12 and 16 years 8 months of age, and ceased to grow shortly after the replacement therapy. The standard deviation score (SDS) for height was -0.9, -1.4, +0.7 and +0.8 at 8, 12, 16 years 8 months and 20 years of age respectively. She showed a unique change in body proportion in her middle teens. At 8, 12, 16 years 8 months and 20 years of age, the SDS for sitting height (SH) was -0.8, -1.1, -0.9 and -0.6 respectively, the SDS for leg length (LL) was - 1.2, - 1.4, + 1.1 and + 1.4 respectively, and the SDS for SH/LL ratio was + 0.6, + 0.4, - 1.6 and - 1.7 respectively. Conclusions: The results provide further support for the notion that the combination of SHOX over-dosage and gonadal estrogen deficiency permits continued growth with a roughly constant height velocity throughout the pubertal period of normal children, and suggest that the height gain in that period is primarily ascribed to the LL increase, as expected from SHOX expression in the distal limb bone.

UR - http://www.scopus.com/inward/record.url?scp=0036677537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036677537&partnerID=8YFLogxK

M3 - Article

C2 - 12153748

AN - SCOPUS:0036677537

VL - 147

SP - 249

EP - 254

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 2

ER -